Based on these results, we propose that hARD1, an endogenous inhibitor of MLCK, plays a critical role in the control of tumor cell behavior, and suggest that hARD1 be viewed as a novel target molecule for the prevention of tumor invasion and metastasis. The gene discussed is NAA10; the disease is neoplasm.